Valuation: Medpace Holdings, Inc.

Market Cap 16.9B 14.64B 13.72B 12.51B 23.53B 1,612B 23.89B 161B 63.07B 807B 63.45B 62.08B 2,691B P/E 2026 *
34.4x
P/E 2027 * 31.6x
Enterprise Value 16.1B 13.95B 13.07B 11.92B 22.41B 1,535B 22.75B 154B 60.08B 769B 60.44B 59.13B 2,564B EV / Sales 2026 *
5.65x
EV / Sales 2027 * 5.17x
Free-Float
79.98%
Yield 2026 *
-
Yield 2027 * -
1 day-0.55%
1 week+2.31%
Current month+4.20%
1 month+13.42%
3 months+43.26%
6 months+44.54%
Current year+7.06%
1 week 576.72
Extreme 576.72
608.18
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Sell

Chief Operating Officer

-7,500 0.0263%
28/07/26 Sell

Chief Executive Officer

-3,510 0.0123%
30/06/26 Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%+2.31%+30.93%+126.39% 16.9B
-1.60%+0.86%+3.70%+14.57% 49.54B
+0.01%+4.79%+486.36%+589.17% 44.06B
-0.48%+9.63%+24.64%+75.91% 40.85B
-0.26%+2.99%+30.77%+10.45% 40.14B
-4.04%+8.72%+22.60%+48.00% 34.17B
+0.85%+5.83% - - 16.78B
-0.43%-0.11%+4.22%+20.71% 14B
+1.57%+9.71%+87.25%+31.87% 13.46B
+0.75%+2.21%-1.15%-35.52% 12.78B
Average -0.32%+6.83%+76.59%+97.95% 28.27B
Weighted average by Cap. -0.64%+6.46%+99.16%+128.77%

Financials

2026 *2027 *
Net sales 2.85B 2.47B 2.31B 2.11B 3.97B 272B 4.03B 27.23B 10.64B 136B 10.71B 10.47B 454B 3.03B 2.62B 2.46B 2.24B 4.21B 289B 4.28B 28.9B 11.3B 145B 11.36B 11.12B 482B
Net income 503M 435M 408M 372M 700M 47.93B 710M 4.8B 1.88B 24B 1.89B 1.85B 80.03B 547M 474M 444M 405M 761M 52.13B 773M 5.22B 2.04B 26.1B 2.05B 2.01B 87.04B
Net Debt -802M -695M -651M -594M -1.12B -76.52B -1.13B -7.66B -2.99B -38.32B -3.01B -2.95B -128B -1.25B -1.08B -1.02B -927M -1.74B -119B -1.77B -11.96B -4.67B -59.8B -4.7B -4.6B -199B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
12/08/26 $602.70 -0.46% 80,746
11/08/26 $605.50 +0.51% 159,911
10/08/26 $602.43 +1.99% 233,638
07/08/26 $590.67 +0.97% 136,483
06/08/26 $585.01 -0.47% 148,658
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
605.50USD
Average target price
581.83USD
Spread / Average Target
-3.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock